Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line

Cancer Genomics and Proteomics

Volumn 6, Issue 4, 2009, Pages 229-237

  Rubporn, Atchara ^a   Srisomsap, Chantragan ^b,c   Subhasitanont, Pantipa ^b   Chokchaichamnankit, Daranee ^b   Chiablaem, Khajeelak ^b   Svasti, Jisnuson ^b,c,d   Sangvanich, Polkit ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Krung Thep Maha Nakhon   (Thailand)

^c Research and Innovation   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Biomarker; Comparative proteomics; Lung cancer; Phosphoprotein; Tandem mass spectrometry

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA ENOLASE; CHAPERONIN; CYTOKERATIN 18; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LAMIN; PHOSPHOPROTEIN; RIBONUCLEOPROTEIN; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; TRANSKETOLASE; TUMOR MARKER;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG FIBROBLAST; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 69549116794     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Meyerson M and Carbone DP: Genomic and proteomic profiling of lung cancers: Lung cancer classification in the age of targeted therapy. J Clin Oncol 23: 3219-3226, 2005. (Pubitemid 46211346)
2. Hjerrild M: Phosphoproteomics toolbox: Computational biology, protein chemistry and mass spectrometry. FEBS Lett 580: 4764-4770, 2006.
3. Yan JX, Packer NH, Gooley AA and Williams KL: Protein phosphorylation: technologies for the identification of phosphoamino acids. J Chromatogr A 808: 23-41, 1998. (Pubitemid 28273216)
4. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Berkelman T and Stenstedt T: 2-D Electrophoresis Using Immobilized pH Gradients; Principles and Methods. Amersham Biosciences, Uppsala, Sweden, 2002.
6. Westermeier R and Naven T: Proteomics in Practice: A Laboratory Manual of Proteome Analysis. Weinheim: Wiley-VCH, 2002.
7. Seiwert TY, Tretiakova M, Ma PC, Khaleque MA, Husain AN, Ladanyi A, Chen LB, Bharti A and Salgia R: Heat shock protein (HSP) over expressed in lung cancer and potential as a therapeutic target. Proc Amer Assoc Cancer Res, 46, 2005.
8. Kim JH, Bogner PN, Ramnath N, Park Y, Yu J and Park YM: Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin Cancer Res 13: 3875-3882, 2007. (Pubitemid 47037594)
9. Yanagawa T, Iwasa S, Ishii T, Tabuchi K, Yusa H, Onizawa K, Omura K, Harada H, Suzuki H and Yoshida H: Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett 156: 27-35, 2000. (Pubitemid 30326764)
10. Qi Y, Chiu JF, Wang L, Kwong DL and He QY: Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5: 2960-2971, 2005. (Pubitemid 41059772)
11. Shen J, Person MD, Zhu J, James L, Abbruzzese JL and Li D: Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64: 9018-9026, 2004. (Pubitemid 39665512)
12. Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki H and Yoshida H: Peroxiredoxin I expression in human thyroid tumors. Cancer Lett 145: 127-132, 1999. (Pubitemid 29459080)
13. Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH and Yoo YJ: Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun 289: 507-512, 2001. (Pubitemid 33141083)
14. Lehtonen ST, Svensk AM, Soini Y, Paakko P, Hirvikoski P, Kang SW, Saily M and Kinnula VL: Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 111: 514-521, 2004. (Pubitemid 39045317)
15. Ibsen KH, Orlando RA, Garrat KN, Hernandez AN, Giolando S and Nungaray G: Expression of multimolecular forms of pyruvate kinase in normal, benign and malignant human breast tissue. Cancer Res 42: 888-892, 1982.
16. Eigenbrodt E, Leib S, Kramer W, Friis RR and Schoner W: Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors. Biomed Biochim Acta 42: S278-282, 1983. (Pubitemid 14130569)
17. Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Li-Han Hsu, Wu CW, Ting CC, Chen CY, Chen KC, Yang TY, Chou TY, Wang WH, Whang-Peng J and Shih NY: Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Over expression Is Associated with Clinical Outcomes, in a tissue-specific manner. Clin Cancer Res 12: 5746-5754, 2006. (Pubitemid 44629605)
18. Yang H, Chen J, Yang J, Qiao S, Zhao S and Yu L: Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 Signal. Biochem and Biophys Res Com 361: 763-767, 2007. (Pubitemid 47238044)
19. Nair RR, Solway J and Boyd DD: Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 281: 26424-26436, 2006. (Pubitemid 44401851)
20. Qi Y, Chiu JF, Wang L, Kwong DL and He QY: Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5: 2960-2971, 2005. (Pubitemid 41059772)
21. Huang Q, Qingling Huang Q, Chen W, Wang L, Lin W, Lin J and Lin X: J Cancer Res Clin Oncol Oncol 134: 1219-1227, 2008.
22. Witt S, Zieseniss A, Fock U, Jockusch BM and Illenberger S: Comparative biochemical analysis suggests that vinculin and metavinculin cooperate in muscular adhesion sites. J Biol Chem 279: 31533-31543, 2004. (Pubitemid 39037822)
23. An MW, Wu WZ and Chen WY: Membrane phospholipid redistribution in cytokinesis: a theoretical model. Acta Biochim Biophys Sin (Shanghai) 37: 643-648, 2005.
24. Cassimeris L: The oncoprotein 18/stathmin family of microtubule destabilizers, Curr Opin Cell Biol 14: 18-24, 2002.